spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Follow-On Biologics 

 HSMN NewsFeed - 19 Jan 2011
Momenta Pharmaceuticals Announces Appointment of Thomas P. Koestler to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Jan 2011
Spectrum Pharmaceuticals to Develop Biosimilar Rituximab
Biopharmaceuticals Oncology Generics
 HSMN NewsFeed - 4 Jan 2011
Momenta Pharmaceuticals Appoints Young T. Kwon as Vice President, Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Feb 2009
Insmed Sells Follow-on Biologics Platform to Merck & Co., Inc. for Gross Proceeds of $130 Million
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 12 Feb 2009
Merck & Co., Inc. Acquires Biologic Manufacturing Capabilities and Developmental Follow-on Biologics Portfolio from Insmed
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 28 Jul 2008
Jim Miller, Ph.D. Joins Insmed Therapeutic Proteins as Vice President of Process Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Jul 2008
Insmed Provides Update on IPLEX(TM) Programs
Biopharmaceuticals
 HSMN NewsFeed - 2 Jun 2008
Huge Potential in Biosimilars if Generic Providers Overcome Regulatory Hurdles
Biopharmaceuticals Generics
 HSMN NewsFeed - 29 Apr 2008
Insmed Provides Update on Follow-On Biologics and IPLEX(TM) Programs
Biopharmaceuticals Generics
 HSMN NewsFeed - 4 Mar 2008
Momenta Pharmaceuticals Appoints Dr. James M. Roach as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Feb 2008
Insmed Launches National Awareness Campaign Surrounding Follow-On Biologics
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 5 Feb 2008
Insmed CEO Issues Statement on White House FY09 Budget and FDA Statements on Follow-On Biologics
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 25 Jun 2007
Experienced Biopharmaceutical Executive Steve Glover Joins Insmed; Will Lead Development of Follow-on Biologics
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 May 2007
Former Immunex Management Team Chosen to Head-Up CTI Subsidiary Aequus BioPharma, Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 May 2007
BIO Urges Congress to Prioritize Patient Safety and Biomedical Innovation in Pathway for Follow-On Biologics
Biopharmaceuticals
 HSMN NewsFeed - 29 Mar 2007
BIO Provides Key Principles on Follow-On Biologics to Legislators
Biopharmaceuticals Generics
 HSMN NewsFeed - 12 Feb 2007
Cell Therapeutics, Inc. (CTI) Spin-off to Use Proprietary Recombinant Genetic Technology to Develop Novel Biopharmaceuticals, Follow-on Biologics and to Deliver siRNA
Biopharmaceuticals
Return to NewsFeed  

 Additional items found! 1

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 1 additional stories matching:
Follow-On Biologics
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.